Jason L.J. Dearling

1.6k total citations
45 papers, 1.2k citations indexed

About

Jason L.J. Dearling is a scholar working on Radiology, Nuclear Medicine and Imaging, Neurology and Cancer Research. According to data from OpenAlex, Jason L.J. Dearling has authored 45 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Neurology and 9 papers in Cancer Research. Recurrent topics in Jason L.J. Dearling's work include Radiopharmaceutical Chemistry and Applications (26 papers), Monoclonal and Polyclonal Antibodies Research (17 papers) and Cancer, Hypoxia, and Metabolism (9 papers). Jason L.J. Dearling is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (26 papers), Monoclonal and Polyclonal Antibodies Research (17 papers) and Cancer, Hypoxia, and Metabolism (9 papers). Jason L.J. Dearling collaborates with scholars based in United States, United Kingdom and Australia. Jason L.J. Dearling's co-authors include Alan B. Packard, Richard H. J. Beǵent, R. Barbara Pedley, S. Ted Treves, Aiden Flynn, Geoffrey M. Boxer, R Boden, Dan Peer, RB Pedley and Ethaar El‐Emir and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and SHILAP Revista de lepidopterología.

In The Last Decade

Jason L.J. Dearling

45 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jason L.J. Dearling United States	21	597	414	308	190	183	45	1.2k
Ali Azhdarinia United States	25	637 1.1×	387 0.9×	408 1.3×	263 1.4×	130 0.7×	66	1.5k
Wilson B. Edwards United States	23	631 1.1×	478 1.2×	414 1.3×	206 1.1×	98 0.5×	59	1.5k
Mickaël Bourgeois France	22	648 1.1×	189 0.5×	319 1.0×	200 1.1×	95 0.5×	45	996
Jean‐Luc Vanderheyden United States	23	875 1.5×	591 1.4×	256 0.8×	246 1.3×	110 0.6×	47	1.5k
Cathelijne Frielink Netherlands	21	736 1.2×	545 1.3×	557 1.8×	343 1.8×	156 0.9×	51	1.8k
Jaspreet Singh Jaggi United States	14	561 0.9×	437 1.1×	268 0.9×	260 1.4×	165 0.9×	15	1.4k
Deborah A. Scollard Canada	23	788 1.3×	356 0.9×	590 1.9×	170 0.9×	85 0.5×	35	1.2k
Martina Rudelius Germany	24	308 0.5×	595 1.4×	594 1.9×	225 1.2×	149 0.8×	43	1.8k
Zhengming Xiong United States	16	574 1.0×	536 1.3×	379 1.2×	161 0.8×	145 0.8×	20	1.4k
Agnieszka Morgenroth Germany	21	270 0.5×	400 1.0×	293 1.0×	170 0.9×	145 0.8×	56	991

Countries citing papers authored by Jason L.J. Dearling

Since Specialization

Citations

This map shows the geographic impact of Jason L.J. Dearling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason L.J. Dearling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason L.J. Dearling more than expected).

Fields of papers citing papers by Jason L.J. Dearling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason L.J. Dearling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason L.J. Dearling. The network helps show where Jason L.J. Dearling may publish in the future.

Co-authorship network of co-authors of Jason L.J. Dearling

This figure shows the co-authorship network connecting the top 25 collaborators of Jason L.J. Dearling. A scholar is included among the top collaborators of Jason L.J. Dearling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason L.J. Dearling. Jason L.J. Dearling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sperotto, Francesca, David M. Harrild, Brian D. Polizzotti, et al.. (2024). Systemically injected oxygen within rapidly dissolving microbubbles improves the outcomes of severe hypoxaemia in swine. Nature Biomedical Engineering. 8(11). 1396–1411. 1 indexed citations

Dearling, Jason L.J., Ellen M. van Dam, Matthew Harris, & Alan B. Packard. (2021). Detection and therapy of neuroblastoma minimal residual disease using [64/67Cu]Cu-SARTATE in a preclinical model of hepatic metastases. EJNMMI Research. 11(1). 20–20. 15 indexed citations

Woodham, Andrew W., Ross W. Cheloha, Mohammad Rashidian, et al.. (2020). In vivo detection of antigen-specific CD8+ T cells by immuno-positron emission tomography. Nature Methods. 17(10). 1025–1032. 36 indexed citations

Butch, Elizabeth R., Paul E. Mead, Heather Tillman, et al.. (2019). Positron Emission Tomography Detects In Vivo Expression of Disialoganglioside GD2 in Mouse Models of Primary and Metastatic Osteosarcoma. Cancer Research. 79(12). 3112–3124. 26 indexed citations

Dearling, Jason L.J. & Alan B. Packard. (2017). Molecular imaging in nanomedicine – A developmental tool and a clinical necessity. Journal of Controlled Release. 261. 23–30. 20 indexed citations

O’Neill, Allison F., Jason L.J. Dearling, Yuchuan Wang, et al.. (2013). Targeted Imaging of Ewing Sarcoma in Preclinical Models Using a 64Cu-Labeled Anti-CD99 Antibody. Clinical Cancer Research. 20(3). 678–687. 17 indexed citations

Dearling, Jason L.J., Jessica W. Barnes, Dipak Panigrahy, et al.. (2013). Specific uptake of 99mTc-NC100692, an αvβ3-targeted imaging probe, in subcutaneous and orthotopic tumors. Nuclear Medicine and Biology. 40(6). 788–794. 16 indexed citations

Vāvere, Amy L., Elizabeth R. Butch, Jason L.J. Dearling, et al.. (2012). ⁶⁴Cu-p-NH₂-Bn-DOTA-hu14.18K322A, a PET Radiotracer Targeting Neuroblastoma and Melanoma. Journal of Nuclear Medicine. 53(11). 1772–1778. 25 indexed citations

Dearling, Jason L.J. & Alan B. Packard. (2011). PET-Radioimmunodetection of Integrins: Imaging Acute Colitis Using a 64Cu-Labeled Anti-β7 Integrin Antibody. Methods in molecular biology. 757. 487–496. 2 indexed citations

10.

Dearling, Jason L.J., Eun Jeong Park, Patricia Dunning, et al.. (2010). Detection of intestinal inflammation by MicroPET imaging using a 64Cu-labeled anti-β7 integrin antibody. Inflammatory Bowel Diseases. 16(9). 1458–1466. 21 indexed citations

11.

Dearling, Jason L.J., Stephan D. Voss, S. Ted Treves, & Alan B. Packard. (2010). Early detection of response to therapy: Reduction of binding of the anti-GD2 antibody ch14.18 to SH-SY5Y neuroblastoma cells precedes retinoic acid effects on cell growth. 51. 1097–1097. 1 indexed citations

12.

Dearling, Jason L.J., Aiden Flynn, Uzma Qureshi, et al.. (2009). Localization of radiolabeled anti-CEA antibody in subcutaneous and intrahepatic colorectal xenografts: influence of tumor size and location within host organ on antibody uptake. Nuclear Medicine and Biology. 36(8). 883–894. 14 indexed citations

13.

Violet, John, et al.. (2008). Fractionated 131I anti-CEA radioimmunotherapy: effects on xenograft tumour growth and haematological toxicity in mice. British Journal of Cancer. 99(4). 632–638. 8 indexed citations

14.

Maxwell, Ross J., R. Barbara Pedley, Jason L.J. Dearling, et al.. (2007). Combretastatin A-4-phosphate effectively increases tumor retention of the therapeutic antibody, 131I-A5B7, even at doses that are sub-optimal for vascular shut-down.. PubMed. 30(2). 453–60. 19 indexed citations

15.

Green, Alan, Aiden Flynn, RB Pedley, Jason L.J. Dearling, & Richard H. J. Beǵent. (2004). Nonuniform Absorbed Dose Distribution in the Kidney: The Influence of Organ Architecture. Cancer Biotherapy and Radiopharmaceuticals. 19(3). 371–377. 9 indexed citations

16.

Mayer, A, Aiden Flynn, RB Pedley, et al.. (2003). Higher Dose and Dose-Rate in Smaller Tumors Result in Improved Tumor Control. Cancer Investigation. 21(3). 382–388. 6 indexed citations

17.

Pedley, RB, Ethaar El‐Emir, Aiden Flynn, et al.. (2002). Synergy between vascular targeting agents and antibody-directed therapy. International Journal of Radiation Oncology*Biology*Physics. 54(5). 1524–1531. 33 indexed citations

18.

Southworth, Richard, et al.. (2002). Dissociation of glucose tracer uptake and glucose transporter distribution in the regionally ischaemic isolated rat heart: application of a new autoradiographic technique. European Journal of Nuclear Medicine and Molecular Imaging. 29(10). 1334–1341. 14 indexed citations

19.

Flynn, Aiden, RB Pedley, Ethaar El‐Emir, et al.. (2002). Spatial accuracy of 3D reconstructed radioluminographs of serial tissue sections and resultant absorbed dose estimates. Physics in Medicine and Biology. 47(20). 3651–3661. 2 indexed citations

20.

Cunningham, David, J.-C. Gazet, H.T. Ford, et al.. (1987). Comparison of antiemetic efficacy of domperidone, metoclopramide, and dexamethasone in patients receiving outpatient chemotherapy regimens.. BMJ. 295(6592). 250–250. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact